US2647121A
(en)
|
1951-02-02 |
1953-07-28 |
Ruth P Jacoby |
Diamine-bis-acetamides
|
US2819718A
(en)
|
1953-07-16 |
1958-01-14 |
Isidore H Goldman |
Drainage tube
|
US2717909A
(en)
|
1953-09-24 |
1955-09-13 |
Monsanto Chemicals |
Hydroxyethyl-keryl-alkylene-ammonium compounds
|
US2844629A
(en)
|
1956-04-25 |
1958-07-22 |
American Home Prod |
Fatty acid amides and derivatives thereof
|
US3096560A
(en)
|
1958-11-21 |
1963-07-09 |
William J Liebig |
Process for synthetic vascular implants
|
GB1072118A
(en)
|
1962-12-01 |
1967-06-14 |
Sandoz Ag |
Amides of aminopropionic acid
|
FR1378382A
(fr)
|
1962-12-01 |
1964-11-13 |
Sandoz Sa |
Amides de l'acide amino-propionique, utilisables en particulier pour le traitement des fibres textiles
|
JPS5141663B1
(es)
|
1966-03-12 |
1976-11-11 |
|
|
NL143127B
(nl)
|
1969-02-04 |
1974-09-16 |
Rhone Poulenc Sa |
Versterkingsorgaan voor een defecte hartklep.
|
US3614955A
(en)
|
1970-02-09 |
1971-10-26 |
Medtronic Inc |
Standby defibrillator and method of operation
|
US3614954A
(en)
|
1970-02-09 |
1971-10-26 |
Medtronic Inc |
Electronic standby defibrillator
|
JPS5024216B1
(es)
|
1970-12-29 |
1975-08-14 |
|
|
US3945052A
(en)
|
1972-05-01 |
1976-03-23 |
Meadox Medicals, Inc. |
Synthetic vascular graft and method for manufacturing the same
|
US3805301A
(en)
|
1972-07-28 |
1974-04-23 |
Meadox Medicals Inc |
Tubular grafts having indicia thereon
|
JPS49127908A
(es)
|
1973-04-20 |
1974-12-07 |
|
|
JPS5624664B2
(es)
|
1973-06-28 |
1981-06-08 |
|
|
US4013507A
(en)
|
1973-09-18 |
1977-03-22 |
California Institute Of Technology |
Ionene polymers for selectively inhibiting the vitro growth of malignant cells
|
JPS5123537A
(ja)
|
1974-04-26 |
1976-02-25 |
Adeka Argus Chemical Co Ltd |
Kasozaisoseibutsu
|
GB1527592A
(en)
|
1974-08-05 |
1978-10-04 |
Ici Ltd |
Wound dressing
|
US3995623A
(en)
|
1974-12-23 |
1976-12-07 |
American Hospital Supply Corporation |
Multipurpose flow-directed catheter
|
JPS5813576B2
(ja)
|
1974-12-27 |
1983-03-14 |
アデカ ア−ガスカガク カブシキガイシヤ |
安定化された合成高分子組成物
|
DE2520814A1
(de)
|
1975-05-09 |
1976-11-18 |
Bayer Ag |
Lichtstabilisierung von polyurethanen
|
US4281669A
(en)
|
1975-05-09 |
1981-08-04 |
Macgregor David C |
Pacemaker electrode with porous system
|
JPS5210847A
(en)
|
1975-07-16 |
1977-01-27 |
Nippon Steel Corp |
Pinch roll
|
US4096860A
(en)
|
1975-10-08 |
1978-06-27 |
Mclaughlin William F |
Dual flow encatheter
|
CA1069652A
(en)
|
1976-01-09 |
1980-01-15 |
Alain F. Carpentier |
Supported bioprosthetic heart valve with compliant orifice ring
|
US4134402A
(en)
|
1976-02-11 |
1979-01-16 |
Mahurkar Sakharam D |
Double lumen hemodialysis catheter
|
US4072146A
(en)
|
1976-09-08 |
1978-02-07 |
Howes Randolph M |
Venous catheter device
|
US4335723A
(en)
|
1976-11-26 |
1982-06-22 |
The Kendall Company |
Catheter having inflatable retention means
|
US4099528A
(en)
|
1977-02-17 |
1978-07-11 |
Sorenson Research Co., Inc. |
Double lumen cannula
|
US4140126A
(en)
|
1977-02-18 |
1979-02-20 |
Choudhury M Hasan |
Method for performing aneurysm repair
|
US4265745A
(en)
|
1977-05-25 |
1981-05-05 |
Teijin Limited |
Permselective membrane
|
US4182833A
(en)
|
1977-12-07 |
1980-01-08 |
Celanese Polymer Specialties Company |
Cationic epoxide-amine reaction products
|
US4180068A
(en)
|
1978-04-13 |
1979-12-25 |
Motion Control, Incorporated |
Bi-directional flow catheter with retractable trocar/valve structure
|
EP0005035B1
(en)
|
1978-04-19 |
1981-09-23 |
Imperial Chemical Industries Plc |
A method of preparing a tubular product by electrostatic spinning
|
US4284459A
(en)
|
1978-07-03 |
1981-08-18 |
The Kendall Company |
Method for making a molded catheter
|
US4227533A
(en)
|
1978-11-03 |
1980-10-14 |
Bristol-Myers Company |
Flushable urinary catheter
|
US4375817A
(en)
|
1979-07-19 |
1983-03-08 |
Medtronic, Inc. |
Implantable cardioverter
|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
DE3010841A1
(de)
|
1980-03-21 |
1981-10-08 |
Ulrich Dr.med. 6936 Haag Uthmann |
Katheder
|
US4308085A
(en)
|
1980-07-28 |
1981-12-29 |
Jenoptik Jena Gmbh |
Process for the preparation of high molecular thermoplastic epoxide-amine-polyadducts
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
US4339369A
(en)
|
1981-04-23 |
1982-07-13 |
Celanese Corporation |
Cationic epoxide-amine reaction products
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
US4406656A
(en)
|
1981-06-01 |
1983-09-27 |
Brack Gillium Hattler |
Venous catheter having collapsible multi-lumens
|
US4475972A
(en)
|
1981-10-01 |
1984-10-09 |
Ontario Research Foundation |
Implantable material
|
US4401472A
(en)
|
1982-02-26 |
1983-08-30 |
Martin Marietta Corporation |
Hydraulic cement mixes and processes for improving hydraulic cement mixes
|
US4568329A
(en)
|
1982-03-08 |
1986-02-04 |
Mahurkar Sakharam D |
Double lumen catheter
|
US4546499A
(en)
|
1982-12-13 |
1985-10-15 |
Possis Medical, Inc. |
Method of supplying blood to blood receiving vessels
|
US4530113A
(en)
|
1983-05-20 |
1985-07-23 |
Intervascular, Inc. |
Vascular grafts with cross-weave patterns
|
US4550447A
(en)
|
1983-08-03 |
1985-11-05 |
Shiley Incorporated |
Vascular graft prosthesis
|
US4647416A
(en)
|
1983-08-03 |
1987-03-03 |
Shiley Incorporated |
Method of preparing a vascular graft prosthesis
|
US5104399A
(en)
|
1986-12-10 |
1992-04-14 |
Endovascular Technologies, Inc. |
Artificial graft and implantation method
|
US4710169A
(en)
|
1983-12-16 |
1987-12-01 |
Christopher T Graham |
Urinary catheter with collapsible urethral tube
|
US4571241A
(en)
|
1983-12-16 |
1986-02-18 |
Christopher T Graham |
Urinary catheter with collapsible urethral tube
|
US4737518A
(en)
|
1984-04-03 |
1988-04-12 |
Takeda Chemical Industries, Ltd. |
Lipid derivatives, their production and use
|
US4562596A
(en)
|
1984-04-25 |
1986-01-07 |
Elliot Kornberg |
Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
|
US4782836A
(en)
|
1984-05-24 |
1988-11-08 |
Intermedics, Inc. |
Rate adaptive cardiac pacemaker responsive to patient activity and temperature
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4662382A
(en)
|
1985-01-16 |
1987-05-05 |
Intermedics, Inc. |
Pacemaker lead with enhanced sensitivity
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
US4860751A
(en)
|
1985-02-04 |
1989-08-29 |
Cordis Corporation |
Activity sensor for pacemaker control
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
CA1320724C
(en)
|
1985-07-19 |
1993-07-27 |
Koichi Kanehira |
Terpene amino alcohols and medicinal uses thereof
|
US4701162A
(en)
|
1985-09-24 |
1987-10-20 |
The Kendall Company |
Foley catheter assembly
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
DE3616824A1
(de)
|
1986-05-17 |
1987-11-19 |
Schering Ag |
Verwendung von haertbaren kunstharzmischungen fuer oberflaechenbeschichtungen und druckfarben und verfahren zu ihrer herstellung
|
EP0255899B1
(de)
|
1986-07-31 |
1992-07-15 |
Werner Prof. Dr.-Ing. Irnich |
Frequenzadaptierender Herzschrittmacher
|
US4960409A
(en)
|
1986-09-11 |
1990-10-02 |
Catalano Marc L |
Method of using bilumen peripheral venous catheter with adapter
|
JPH0829776B2
(ja)
|
1986-10-29 |
1996-03-27 |
東燃化学株式会社 |
合成樹脂製容器及びその製造用金型
|
US4720517A
(en)
|
1986-11-24 |
1988-01-19 |
Ciba-Geigy Corporation |
Compositions stabilized with N-hydroxyiminodiacetic and dipropionic acids and esters thereof
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
DE3728917A1
(de)
|
1987-08-29 |
1989-03-09 |
Roth Hermann J |
Neue lipide mit unsymmetrisch substituierter disulfidbruecke
|
US4946683A
(en)
|
1987-11-18 |
1990-08-07 |
Vestar, Inc. |
Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
|
US5047540A
(en)
|
1987-12-17 |
1991-09-10 |
Shionogi & Co., Ltd. |
Lipid derivatives
|
US5138067A
(en)
|
1987-12-17 |
1992-08-11 |
Shionogi & Co. Ltd. |
Lipid derivatives
|
US4892540A
(en)
|
1988-04-21 |
1990-01-09 |
Sorin Biomedica S.P.A. |
Two-leaflet prosthetic heart valve
|
US5176661A
(en)
|
1988-09-06 |
1993-01-05 |
Advanced Cardiovascular Systems, Inc. |
Composite vascular catheter
|
US5024671A
(en)
|
1988-09-19 |
1991-06-18 |
Baxter International Inc. |
Microporous vascular graft
|
US5200395A
(en)
|
1988-10-18 |
1993-04-06 |
Ajinomoto Company, Inc. |
Pharmaceutical composition of BUF-5 for treating anemia
|
CA2001401A1
(en)
|
1988-10-25 |
1990-04-25 |
Claude Piantadosi |
Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
DE69032284T2
(de)
|
1989-03-21 |
1998-10-08 |
Vical, Inc., San Diego, Calif. |
Expression von exogenen polynukleotidsequenzen in wirbeltieren
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
FR2645866B1
(fr)
|
1989-04-17 |
1991-07-05 |
Centre Nat Rech Scient |
Nouvelles lipopolyamines, leur preparation et leur emploi
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
US5101824A
(en)
|
1990-04-16 |
1992-04-07 |
Siemens-Pacesetter, Inc. |
Rate-responsive pacemaker with circuitry for processing multiple sensor inputs
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
WO1992001425A1
(en)
|
1990-07-26 |
1992-02-06 |
Rodney James Lane |
Self expanding vascular endoprosthesis for aneurysms
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
JPH0765267B2
(ja)
|
1990-08-22 |
1995-07-12 |
花王株式会社 |
柔軟仕上剤
|
ES2085435T3
(es)
|
1990-10-09 |
1996-06-01 |
Cook Inc |
Dispositivo dilatador percutaneo.
|
EP0491082B1
(de)
|
1990-12-19 |
1995-04-12 |
Peter Dr. Ing. Osypka |
Herzschrittmacherleitung mit einem inneren Kanal und mit einem Elektrodenkopf
|
US5116360A
(en)
|
1990-12-27 |
1992-05-26 |
Corvita Corporation |
Mesh composite graft
|
US5405363A
(en)
|
1991-03-15 |
1995-04-11 |
Angelon Corporation |
Implantable cardioverter defibrillator having a smaller displacement volume
|
US5330768A
(en)
|
1991-07-05 |
1994-07-19 |
Massachusetts Institute Of Technology |
Controlled drug delivery using polymer/pluronic blends
|
US5545449A
(en)
|
1991-10-02 |
1996-08-13 |
Weyerhaeuser Company |
Polyether-reinforced fiber-based materials
|
US5151105A
(en)
|
1991-10-07 |
1992-09-29 |
Kwan Gett Clifford |
Collapsible vessel sleeve implant
|
US5284491A
(en)
|
1992-02-27 |
1994-02-08 |
Medtronic, Inc. |
Cardiac pacemaker with hysteresis behavior
|
US5352461A
(en)
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
SE9200951D0
(sv)
|
1992-03-27 |
1992-03-27 |
Kabi Pharmacia Ab |
Pharmaceutical composition containing a defined lipid system
|
CA2132342A1
(en)
|
1992-04-06 |
1993-10-14 |
Kenneth F. Buechler |
Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
CA2141685A1
(en)
|
1992-08-04 |
1994-02-17 |
Koji Naito |
Antiallergic composition
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
US5461223A
(en)
|
1992-10-09 |
1995-10-24 |
Eastman Kodak Company |
Bar code detecting circuitry
|
US5300022A
(en)
|
1992-11-12 |
1994-04-05 |
Martin Klapper |
Urinary catheter and bladder irrigation system
|
US5496362A
(en)
|
1992-11-24 |
1996-03-05 |
Cardiac Pacemakers, Inc. |
Implantable conformal coil patch electrode with multiple conductive elements for cardioversion and defibrillation
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
US5716395A
(en)
|
1992-12-11 |
1998-02-10 |
W.L. Gore & Associates, Inc. |
Prosthetic vascular graft
|
CA2156288C
(en)
|
1993-02-19 |
2005-10-18 |
Junichi Yano |
Glycerol derivative, device and pharmaceutical composition
|
US5395619A
(en)
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
US5697953A
(en)
|
1993-03-13 |
1997-12-16 |
Angeion Corporation |
Implantable cardioverter defibrillator having a smaller displacement volume
|
US5624976A
(en)
|
1994-03-25 |
1997-04-29 |
Dentsply Gmbh |
Dental filling composition and method
|
US5314430A
(en)
|
1993-06-24 |
1994-05-24 |
Medtronic, Inc. |
Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use
|
DE4325848A1
(de)
|
1993-07-31 |
1995-02-02 |
Basf Ag |
Verfahren zur Herstellung von N-(2-Hydroxyethyl)-piperazin
|
EP0875280B1
(en)
|
1993-10-06 |
2001-08-22 |
The Kansai Electric Power Co., Inc. |
Method for removing carbon dioxide from combustion exhaust gas
|
US5609624A
(en)
|
1993-10-08 |
1997-03-11 |
Impra, Inc. |
Reinforced vascular graft and method of making same
|
SE9303481L
(sv)
|
1993-10-22 |
1995-04-23 |
Berol Nobel Ab |
Hygienkomposition
|
WO1995013033A1
(en)
|
1993-11-08 |
1995-05-18 |
Lazarus Harrison M |
Intraluminal vascular graft and method
|
CA2176714A1
(en)
|
1993-11-24 |
1995-06-01 |
Timothy D. Heath |
Amphiphilic derivatives of piperazine
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
US5464924A
(en)
|
1994-01-07 |
1995-11-07 |
The Dow Chemical Company |
Flexible poly(amino ethers) for barrier packaging
|
US5844107A
(en)
|
1994-03-23 |
1998-12-01 |
Case Western Reserve University |
Compacted nucleic acids and their delivery to cells
|
DK0758883T3
(da)
|
1994-04-12 |
2003-06-02 |
Liposome Co Inc |
Fusogene liposomer og fremgangsmåder til fremstilling af og anvendelse af disse
|
US5833979A
(en)
|
1994-07-20 |
1998-11-10 |
Cytotherapeutics, Inc. |
Methods and compositions of growth control for cells encapsulated within bioartificial organs
|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
US5641665A
(en)
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
US6071890A
(en)
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
US5965434A
(en)
|
1994-12-29 |
1999-10-12 |
Wolff; Jon A. |
Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds
|
US6485726B1
(en)
|
1995-01-17 |
2002-11-26 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
JP2001523215A
(ja)
|
1995-04-17 |
2001-11-20 |
イマークス ファーマシューティカル コーポレーション |
ハイブリッド磁気共鳴造影剤
|
US5772694A
(en)
|
1995-05-16 |
1998-06-30 |
Medical Carbon Research Institute L.L.C. |
Prosthetic heart valve with improved blood flow
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
US5783383A
(en)
|
1995-05-23 |
1998-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of detecting cytomegalovirus (CMV)
|
US5981501A
(en)
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
IL122290A0
(en)
|
1995-06-07 |
1998-04-05 |
Inex Pharmaceuticals Corp |
Lipid-nucleic acid complex its preparation and use
|
US5705385A
(en)
|
1995-06-07 |
1998-01-06 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US5609629A
(en)
|
1995-06-07 |
1997-03-11 |
Med Institute, Inc. |
Coated implantable medical device
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US5607385A
(en)
|
1995-08-17 |
1997-03-04 |
Medtronic, Inc. |
Device and algorithm for a combined cardiomyostimulator and a cardiac pacer-carioverter-defibrillator
|
US5744335A
(en)
|
1995-09-19 |
1998-04-28 |
Mirus Corporation |
Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
|
FR2740978B1
(fr)
|
1995-11-10 |
1998-01-02 |
Ela Medical Sa |
Dispositif medical actif du type defibrillateur/cardioverteur implantable
|
US5874105A
(en)
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
ATE273320T1
(de)
|
1996-04-11 |
2004-08-15 |
Univ British Columbia |
Fusogene liposomen
|
US5935936A
(en)
|
1996-06-03 |
1999-08-10 |
Genzyme Corporation |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
|
US5913848A
(en)
|
1996-06-06 |
1999-06-22 |
Luther Medical Products, Inc. |
Hard tip over-the-needle catheter and method of manufacturing the same
|
US5677124A
(en)
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
US5736573A
(en)
|
1996-07-31 |
1998-04-07 |
Galat; Alexander |
Lipid and water soluble derivatives of drugs
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
AU729077B2
(en)
|
1996-08-26 |
2001-01-25 |
Transgene S.A. |
Cationic lipid-nucleic acid complexes
|
EP0938298B1
(en)
|
1996-09-13 |
2002-12-04 |
Lipoxen Technologies Limited |
Liposome-based composition
|
TW520297B
(en)
|
1996-10-11 |
2003-02-11 |
Sequus Pharm Inc |
Fusogenic liposome composition and method
|
WO1998019709A2
(en)
|
1996-11-04 |
1998-05-14 |
Qiagen Gmbh |
Cationic reagents for transfection
|
US6887665B2
(en)
|
1996-11-14 |
2005-05-03 |
Affymetrix, Inc. |
Methods of array synthesis
|
US5985930A
(en)
|
1996-11-21 |
1999-11-16 |
Pasinetti; Giulio M. |
Treatment of neurodegenerative conditions with nimesulide
|
US6204297B1
(en)
|
1996-11-26 |
2001-03-20 |
Rhodia Inc. |
Nonionic gemini surfactants
|
JPH10197978A
(ja)
|
1997-01-09 |
1998-07-31 |
Mitsubishi Paper Mills Ltd |
ハロゲン化銀写真感光材料
|
EP0853123A1
(de)
|
1997-01-10 |
1998-07-15 |
Roche Diagnostics GmbH |
Reinigung von DNA durch Cross-Flow-Filtration
|
FR2760193B1
(fr)
|
1997-02-28 |
1999-05-28 |
Transgene Sa |
Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
US5945326A
(en)
|
1997-03-20 |
1999-08-31 |
New England Biolabs, Inc. |
Method for cloning and producing the Spel restriction endonuclease
|
EP1027033B1
(en)
|
1997-05-14 |
2009-07-22 |
The University Of British Columbia |
High efficiency encapsulation of nucleic acids in lipid vesicles
|
US6835395B1
(en)
|
1997-05-14 |
2004-12-28 |
The University Of British Columbia |
Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
|
US20030104044A1
(en)
|
1997-05-14 |
2003-06-05 |
Semple Sean C. |
Compositions for stimulating cytokine secretion and inducing an immune response
|
JPH115786A
(ja)
|
1997-06-13 |
1999-01-12 |
Pola Chem Ind Inc |
新規アミノヒドロキシプロピルピペラジン誘導体
|
US6067471A
(en)
|
1998-08-07 |
2000-05-23 |
Cardiac Pacemakers, Inc. |
Atrial and ventricular implantable cardioverter-defibrillator and lead system
|
JPH1180142A
(ja)
|
1997-09-05 |
1999-03-26 |
Pola Chem Ind Inc |
ジフェニルアルキル化合物の製造法
|
EP1021549A2
(en)
|
1997-09-19 |
2000-07-26 |
Sequitur, Inc. |
SENSE mRNA THERAPY
|
US6165763A
(en)
|
1997-10-30 |
2000-12-26 |
Smithkline Beecham Corporation |
Ornithine carbamoyltransferase
|
US6096075A
(en)
|
1998-01-22 |
2000-08-01 |
Medical Carbon Research Institute, Llc |
Prosthetic heart valve
|
US6617171B2
(en)
|
1998-02-27 |
2003-09-09 |
The General Hospital Corporation |
Methods for diagnosing and treating autoimmune disease
|
US6271209B1
(en)
|
1998-04-03 |
2001-08-07 |
Valentis, Inc. |
Cationic lipid formulation delivering nucleic acid to peritoneal tumors
|
US6176877B1
(en)
|
1998-04-20 |
2001-01-23 |
St. Jude Medical, Inc. |
Two piece prosthetic heart valve
|
DE19822602A1
(de)
|
1998-05-20 |
1999-11-25 |
Goldschmidt Ag Th |
Verfahren zur Herstellung von Polyaminosäureestern durch Veresterung von sauren Polyaminosäuren oder Umesterung von Polyaminosäureestern
|
NO313244B1
(no)
|
1998-07-08 |
2002-09-02 |
Crew Dev Corp |
Fremgangsmåte for isolering og produksjon av magnesitt eller magnesiumklorid
|
US6055454A
(en)
|
1998-07-27 |
2000-04-25 |
Cardiac Pacemakers, Inc. |
Cardiac pacemaker with automatic response optimization of a physiologic sensor based on a second sensor
|
KR20010072816A
(ko)
|
1998-08-20 |
2001-07-31 |
쿡 인코포레이티드 |
피복된 삽입용 의료 장치
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
AU1830200A
(en)
|
1998-11-25 |
2000-06-13 |
Vanderbilt University |
Cationic liposomes for gene transfer
|
US6248725B1
(en)
|
1999-02-23 |
2001-06-19 |
Amgen, Inc. |
Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
|
US6379698B1
(en)
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
AU783647B2
(en)
|
1999-04-20 |
2005-11-17 |
University Of British Columbia, The |
Cationic peg-lipids and methods of use
|
IL146055A0
(en)
|
1999-04-23 |
2002-07-25 |
Alza Corp |
Conjugate having a cleavable linkage for use in a liposome
|
US6169923B1
(en)
|
1999-04-23 |
2001-01-02 |
Pacesetter, Inc. |
Implantable cardioverter-defibrillator with automatic arrhythmia detection criteria adjustment
|
DE60035871T2
(de)
|
1999-05-19 |
2008-06-05 |
Merck Patent Gmbh |
Expression und export von interferon-alpha proteinen als fc fusionsproteine
|
US6696424B1
(en)
|
1999-05-28 |
2004-02-24 |
Vical Incorporated |
Cytofectin dimers and methods of use thereof
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
WO2001005375A1
(en)
|
1999-07-16 |
2001-01-25 |
Purdue Research Foundation |
Vinyl ether lipids with cleavable hydrophilic headgroups
|
CA2378944A1
(en)
|
1999-07-23 |
2001-02-01 |
Genentech, Inc. |
Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration
|
US6358278B1
(en)
|
1999-09-24 |
2002-03-19 |
St. Jude Medical, Inc. |
Heart valve prosthesis with rotatable cuff
|
US6371983B1
(en)
|
1999-10-04 |
2002-04-16 |
Ernest Lane |
Bioprosthetic heart valve
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
EP1242609A2
(en)
|
1999-12-30 |
2002-09-25 |
Novartis AG |
Novel colloid synthetic vectors for gene therapy
|
CA2400634A1
(en)
|
2000-02-17 |
2001-08-23 |
Chester Li |
Genetic modification of the lung as a portal for gene delivery
|
US6370434B1
(en)
|
2000-02-28 |
2002-04-09 |
Cardiac Pacemakers, Inc. |
Cardiac lead and method for lead implantation
|
US6565960B2
(en)
|
2000-06-01 |
2003-05-20 |
Shriners Hospital Of Children |
Polymer composite compositions
|
EP1297169B1
(en)
|
2000-06-26 |
2012-08-08 |
Ethris Gmbh |
Method for transfecting cells using a magnetic field
|
IL138474A0
(en)
|
2000-09-14 |
2001-10-31 |
Epox Ltd |
Highly branched water-soluble polyamine oligomers, process for their preparation and applications thereof
|
US6998115B2
(en)
|
2000-10-10 |
2006-02-14 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
USRE43612E1
(en)
|
2000-10-10 |
2012-08-28 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
US7427394B2
(en)
|
2000-10-10 |
2008-09-23 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
JP2004511572A
(ja)
|
2000-10-25 |
2004-04-15 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
標的化送達のための脂質製剤
|
GB0028361D0
(en)
|
2000-11-21 |
2001-01-03 |
Glaxo Group Ltd |
Method of separating extra chromosomal dna from other cellular components
|
US20020094528A1
(en)
|
2000-11-29 |
2002-07-18 |
Salafsky Joshua S. |
Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interations
|
JP2002167368A
(ja)
|
2000-12-01 |
2002-06-11 |
Nitto Denko Corp |
アルキル置換デンドリマーおよびその製造法
|
US20050004058A1
(en)
|
2000-12-07 |
2005-01-06 |
Patrick Benoit |
Sequences upstream of the carp gene, vectors containing them and uses thereof
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
US20020192721A1
(en)
|
2001-03-28 |
2002-12-19 |
Engeneos, Inc. |
Modular molecular clasps and uses thereof
|
TW588032B
(en)
|
2001-04-23 |
2004-05-21 |
Shinetsu Chemical Co |
New tertiary amine compound having ester structure and method for producing the same
|
US6585410B1
(en)
|
2001-05-03 |
2003-07-01 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Radiant temperature nulling radiometer
|
DE50214200D1
(de)
|
2001-06-05 |
2010-03-25 |
Curevac Gmbh |
Stabilisierte Tumorantigen-mRNA mit erhöhtem G/C-Gehalt
|
EP2428568B1
(en)
|
2001-09-28 |
2018-04-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
EP1446665A2
(de)
|
2001-11-09 |
2004-08-18 |
Bayer HealthCare AG |
Isotopencodierte affinitätsmarker 3
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
DE10214983A1
(de)
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
US20030215395A1
(en)
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
US7601367B2
(en)
|
2002-05-28 |
2009-10-13 |
Mirus Bio Llc |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
US7901708B2
(en)
|
2002-06-28 |
2011-03-08 |
Protiva Biotherapeutics, Inc. |
Liposomal apparatus and manufacturing methods
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
US20040028804A1
(en)
|
2002-08-07 |
2004-02-12 |
Anderson Daniel G. |
Production of polymeric microarrays
|
EP1539936A2
(en)
|
2002-08-22 |
2005-06-15 |
Celltran Limited |
Cell culture surface
|
US7563857B2
(en)
|
2002-11-04 |
2009-07-21 |
Momentive Performance Materials Gmbh |
Linear polyamino and/or polyammonium polysiloxane copolymers I
|
EP1572669A2
(en)
|
2002-11-22 |
2005-09-14 |
Novo Nordisk A/S |
2,5-diketopiperazines for the treatment of obesity
|
US7169892B2
(en)
|
2003-01-10 |
2007-01-30 |
Astellas Pharma Inc. |
Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
|
WO2004066138A1
(ja)
|
2003-01-20 |
2004-08-05 |
Asahi Kasei Emd Corporation |
ポインティングデバイス
|
NZ542665A
(en)
|
2003-03-05 |
2008-05-30 |
Senesco Technologies Inc |
Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
|
US20040224912A1
(en)
|
2003-05-07 |
2004-11-11 |
Isis Pharmaceuticals Inc. |
Modulation of PAI-1 mRNA-binding protein expression
|
US7619017B2
(en)
|
2003-05-19 |
2009-11-17 |
Wacker Chemical Corporation |
Polymer emulsions resistant to biodeterioration
|
WO2005007810A2
(en)
|
2003-06-16 |
2005-01-27 |
Grinstaff Mark W |
Functional synthetic molecules and macromolecules for gene delivery
|
US7803397B2
(en)
|
2003-09-15 |
2010-09-28 |
Protiva Biotherapeutics, Inc. |
Polyethyleneglycol-modified lipid compounds and uses thereof
|
CA2539670A1
(en)
|
2003-09-15 |
2005-03-31 |
Massachusetts Institute Of Technology |
Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
|
US20050069590A1
(en)
|
2003-09-30 |
2005-03-31 |
Buehler Gail K. |
Stable suspensions for medicinal dosages
|
AU2004279991B2
(en)
|
2003-10-10 |
2010-11-25 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
WO2005037226A2
(en)
|
2003-10-17 |
2005-04-28 |
Georgia Tech Research Corporation |
Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders
|
EP1683784A4
(en)
|
2003-11-10 |
2007-08-22 |
Nippon Kayaku Kk |
DIIMONIUM SALT CONNECTION AND ITS USE
|
US7022214B2
(en)
|
2004-01-21 |
2006-04-04 |
Bio-Rad Laboratories, Inc. |
Carrier ampholytes of high pH range
|
US7556684B2
(en)
|
2004-02-26 |
2009-07-07 |
Construction Research & Technology Gmbh |
Amine containing strength improvement admixture
|
US20060228404A1
(en)
|
2004-03-04 |
2006-10-12 |
Anderson Daniel G |
Compositions and methods for treatment of hypertrophic tissues
|
AU2005251403B2
(en)
|
2004-06-07 |
2011-09-01 |
Arbutus Biopharma Corporation |
Cationic lipids and methods of use
|
AU2005252273B2
(en)
|
2004-06-07 |
2011-04-28 |
Arbutus Biopharma Corporation |
Lipid encapsulated interfering RNA
|
US7670595B2
(en)
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
GB0418172D0
(en)
|
2004-08-13 |
2004-09-15 |
Ic Vec Ltd |
Vector
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
DE102004043342A1
(de)
|
2004-09-08 |
2006-03-09 |
Bayer Materialscience Ag |
Blockierte Polyurethan-Prepolymere als Klebstoffe
|
CA2586708A1
(en)
|
2004-11-05 |
2006-05-11 |
Novosom Ag |
Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent
|
GB0502482D0
(en)
|
2005-02-07 |
2005-03-16 |
Glaxo Group Ltd |
Novel compounds
|
CA2597724A1
(en)
|
2005-02-14 |
2007-08-02 |
Sirna Therapeutics, Inc. |
Cationic lipids and formulated molecular compositions containing them
|
EP1869106B1
(en)
|
2005-03-28 |
2014-06-25 |
Dendritic Nanotechnologies, Inc. |
Janus dendrimers and dendrons
|
EP1912679A4
(en)
|
2005-06-15 |
2009-07-29 |
Massachusetts Inst Technology |
AMINOUS LIPIDS AND ITS USES
|
ES2735531T3
(es)
|
2005-08-23 |
2019-12-19 |
Univ Pennsylvania |
ARN que contiene nucleósidos modificados y métodos de uso del mismo
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
WO2007031091A2
(en)
|
2005-09-15 |
2007-03-22 |
Santaris Pharma A/S |
Rna antagonist compounds for the modulation of p21 ras expression
|
WO2007051303A1
(en)
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
US7238791B1
(en)
|
2005-12-16 |
2007-07-03 |
Roche Diagnostics Operations, Inc. |
6-monoacetylmorphine derivatives useful in immunoassay
|
WO2007073489A2
(en)
|
2005-12-22 |
2007-06-28 |
Trustees Of Boston University |
Molecules for gene delivery and gene therapy, and methods of use thereof
|
CN100569877C
(zh)
|
2005-12-30 |
2009-12-16 |
财团法人工业技术研究院 |
含多uv交联反应基的分枝状结构化合物及其应用
|
CA2649325C
(en)
|
2006-04-14 |
2019-01-08 |
Epicentre Technologies Corporation |
Kits and methods for generating 5' capped rna
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
US20070275923A1
(en)
|
2006-05-25 |
2007-11-29 |
Nastech Pharmaceutical Company Inc. |
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
|
EP2032652A4
(en)
|
2006-06-05 |
2011-08-17 |
Massachusetts Inst Technology |
NETWORKED DEVELOPABLE POLYMERS AND ITS USE
|
US20090186805A1
(en)
|
2006-07-06 |
2009-07-23 |
Aaron Thomas Tabor |
Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
|
ES2293834B1
(es)
|
2006-07-20 |
2009-02-16 |
Consejo Superior Investig. Cientificas |
Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas.
|
CA2658768C
(en)
|
2006-07-21 |
2016-05-17 |
Massachusetts Institute Of Technology |
End-modified poly(beta-amino esters) and uses thereof
|
MX2009003548A
(es)
|
2006-10-03 |
2009-04-15 |
Alnylam Pharmaceuticals Inc |
Formulaciones que contienen lipidos.
|
CA2665620A1
(en)
*
|
2006-10-12 |
2008-04-17 |
Copernicus Therapeutics Inc. |
Codon optimized cftr
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
US8268586B2
(en)
|
2006-12-21 |
2012-09-18 |
Novozymes, Inc. |
Modified messenger RNA stabilizing sequences for expressing genes in bacterial cells
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
US8859229B2
(en)
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
EP2139461A2
(en)
|
2007-03-20 |
2010-01-06 |
Recepticon Aps |
Amino derivatives to prevent nephrotoxicity and cancer
|
JP5186126B2
(ja)
|
2007-03-29 |
2013-04-17 |
公益財団法人地球環境産業技術研究機構 |
新規トリアジン誘導体ならびにその製法およびそのガス分離膜としての用途
|
EP2144609B1
(en)
|
2007-04-18 |
2014-10-29 |
Cornerstone Pharmaceuticals, Inc. |
Pharmaceutical formulations containing lipoic acid derivatives
|
US8678686B2
(en)
|
2007-05-01 |
2014-03-25 |
Pgr-Solutions |
Multi-chain lipophilic polyamines
|
US20090163705A1
(en)
|
2007-05-21 |
2009-06-25 |
Alnylam Pharmaceuticals, Inc. |
Cationic lipids
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
WO2009036280A1
(en)
|
2007-09-12 |
2009-03-19 |
Copernicus Therapeutics, Inc. |
Long-term in vivo transgene expression
|
NZ584048A
(en)
|
2007-10-02 |
2012-08-31 |
Marina Biotech Inc |
Lipopeptides for delivery of nucleic acids
|
WO2009046739A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating prostate cancer (pca)
|
EP2221371B1
(en)
|
2007-11-22 |
2013-11-13 |
Japan Science and Technology Agency |
Translation regulation system in cell or artificial cell model by using low-molecular-weight rna
|
CA2910760C
(en)
|
2007-12-04 |
2019-07-09 |
Muthiah Manoharan |
Targeting lipids
|
WO2009120247A2
(en)
|
2007-12-27 |
2009-10-01 |
The Ohio State University Research Foundation |
Lipid nanoparticle compositions and methods of making and using the same
|
AU2008342535B2
(en)
|
2007-12-27 |
2015-02-05 |
Arbutus Biopharma Corporation |
Silencing of polo-like kinase expression using interfering RNA
|
WO2009088891A1
(en)
|
2008-01-02 |
2009-07-16 |
Alnylam Pharmaceuticals, Inc. |
Screening method for selected amino lipid-containing compositions
|
WO2009126933A2
(en)
|
2008-04-11 |
2009-10-15 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
CN102119217B
(zh)
|
2008-04-15 |
2015-06-03 |
普洛体维生物治疗公司 |
用于核酸递送的新型制剂
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
US20090263407A1
(en)
|
2008-04-16 |
2009-10-22 |
Abbott Laboratories |
Cationic Lipids and Uses Thereof
|
US8222221B2
(en)
|
2008-06-04 |
2012-07-17 |
The Board Of Regents Of The University Of Texas System |
Modulation of gene expression through endogenous small RNA targeting of gene promoters
|
US20100035249A1
(en)
|
2008-08-05 |
2010-02-11 |
Kabushiki Kaisha Dnaform |
Rna sequencing and analysis using solid support
|
US8404198B2
(en)
|
2008-08-27 |
2013-03-26 |
Life Technologies Corporation |
Apparatus for and method of processing biological samples
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
CA2740000C
(en)
|
2008-10-09 |
2017-12-12 |
Tekmira Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
WO2010045512A2
(en)
|
2008-10-16 |
2010-04-22 |
Mdrna , Inc. |
Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics
|
US9080211B2
(en)
|
2008-10-24 |
2015-07-14 |
Epicentre Technologies Corporation |
Transposon end compositions and methods for modifying nucleic acids
|
US20120009222A1
(en)
|
2008-10-27 |
2012-01-12 |
Massachusetts Institute Of Technology |
Modulation of the immune response
|
JP6087504B2
(ja)
|
2008-11-07 |
2017-03-01 |
マサチューセッツ インスティテュート オブ テクノロジー |
アミノアルコールリピドイドおよびその使用
|
KR102344392B1
(ko)
|
2008-11-10 |
2021-12-28 |
알닐람 파마슈티칼스 인코포레이티드 |
치료제 운반용 신규 지질 및 조성물
|
CN102216462A
(zh)
|
2008-11-17 |
2011-10-12 |
安龙制药公司 |
用于核酸递送***的支化阳离子脂质
|
US9023820B2
(en)
|
2009-01-26 |
2015-05-05 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein C-III expression
|
US20100222489A1
(en)
|
2009-02-27 |
2010-09-02 |
Jiang Dayue D |
Copolymer composition, membrane article, and methods thereof
|
NZ594995A
(en)
|
2009-03-12 |
2013-06-28 |
Alnylam Pharmaceuticals Inc |
LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF HUMAN KINESIN FAMILY MEMBER 11 (Eg5) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENES
|
CN102334237B
(zh)
|
2009-04-02 |
2015-05-13 |
西蒙公司 |
电信接线板
|
PT2419144T
(pt)
|
2009-04-17 |
2019-09-16 |
Univ Oxford Innovation Ltd |
Composição para a administração de material genético
|
US9220682B2
(en)
|
2009-04-22 |
2015-12-29 |
Emory University |
Nanocarrier therapy for treating invasive tumors
|
NZ621981A
(en)
|
2009-05-05 |
2015-09-25 |
Tekmira Pharmaceuticals Corp |
Lipid compositions
|
EA201791744A3
(ru)
|
2009-06-10 |
2018-07-31 |
Арбутус Биофарма Корпорэйшн |
Улучшенная липидная композиция
|
US8273869B2
(en)
|
2009-06-15 |
2012-09-25 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated dsRNA targeting the PCSK9 gene
|
US9051567B2
(en)
|
2009-06-15 |
2015-06-09 |
Tekmira Pharmaceuticals Corporation |
Methods for increasing efficacy of lipid formulated siRNA
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
CA2767129C
(en)
|
2009-07-01 |
2015-01-06 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein b
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
CN102574818B
(zh)
|
2009-07-30 |
2015-02-25 |
萨尔瓦特实验室股份有限公司 |
Apaf-1抑制剂化合物
|
DK2459231T3
(en)
|
2009-07-31 |
2016-09-05 |
Ethris Gmbh |
RNA with a combination of unmodified and modified nucleotides for protein expression
|
DE102009043342A1
(de)
|
2009-09-29 |
2011-03-31 |
Bayer Technology Services Gmbh |
Stoffe für selbstorganisierte Träger zur kontrollierten Freisetzung eines Wirkstoffs
|
NZ700688A
(en)
|
2009-12-01 |
2016-02-26 |
Shire Human Genetic Therapies |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
EP3623474A1
(en)
|
2009-12-07 |
2020-03-18 |
The Trustees of The University of Pennsylvania |
Rna preparations comprising purified modified rna for reprogramming cells
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
ES2749426T3
(es)
|
2009-12-18 |
2020-03-20 |
Univ British Columbia |
Métodos y composiciones para administración de ácidos nucleicos
|
EP2338520A1
(de)
|
2009-12-21 |
2011-06-29 |
Ludwig Maximilians Universität |
Konjugat mit Zielfindungsligand und dessen Verwendung
|
AU2010334911A1
(en)
|
2009-12-23 |
2012-07-12 |
Novartis Ag |
Lipids, lipid compositions, and methods of using them
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
DK2575764T3
(en)
|
2010-06-03 |
2017-08-07 |
Alnylam Pharmaceuticals Inc |
BIODEGRADABLE LIPIDS FOR THE ACTIVATION OF ACTIVE AGENTS
|
CN101863544B
(zh)
|
2010-06-29 |
2011-09-28 |
湖南科技大学 |
一种氰尿酸基重金属螯合絮凝剂及其制备方法
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
WO2012016184A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2012019630A1
(en)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
|
WO2012027675A2
(en)
|
2010-08-26 |
2012-03-01 |
Massachusetts Institute Of Technology |
Poly(beta-amino alcohols), their preparation, and uses thereof
|
HUE058896T2
(hu)
|
2010-10-01 |
2022-09-28 |
Modernatx Inc |
N1-metil-pszeudo-uracilt tartalmazó ribonukleinsavak és azok felhasználásai
|
US8853377B2
(en)
|
2010-11-30 |
2014-10-07 |
Shire Human Genetic Therapies, Inc. |
mRNA for use in treatment of human genetic diseases
|
WO2012113413A1
(en)
|
2011-02-21 |
2012-08-30 |
Curevac Gmbh |
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
|
EP2691443B1
(en)
|
2011-03-28 |
2021-02-17 |
Massachusetts Institute of Technology |
Conjugated lipomers and uses thereof
|
WO2012133737A1
(ja)
|
2011-03-31 |
2012-10-04 |
公益財団法人地球環境産業技術研究機構 |
架橋性アミン化合物、該化合物を用いた高分子膜及びその製造方法
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
EP2705152B1
(en)
|
2011-05-04 |
2017-10-25 |
The Broad Institute, Inc. |
Multiplexed genetic reporter assays and compositions
|
CN103687957A
(zh)
|
2011-05-17 |
2014-03-26 |
现代治疗公司 |
工程化核酸及其用于非人类脊椎动物的方法
|
EP2532649B1
(en)
|
2011-06-07 |
2015-04-08 |
Incella GmbH |
Amino lipids, their synthesis and uses thereof
|
AU2012267578B2
(en)
|
2011-06-08 |
2017-04-20 |
Translate Bio, Inc. |
Cleavable lipids
|
JP6184945B2
(ja)
|
2011-06-08 |
2017-08-23 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
mRNA送達のための脂質ナノ粒子組成物および方法
|
WO2013003475A1
(en)
|
2011-06-27 |
2013-01-03 |
Cellscript, Inc. |
Inhibition of innate immune response
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP3384938A1
(en)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2013039857A1
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
RS62993B1
(sr)
|
2011-10-03 |
2022-03-31 |
Modernatx Inc |
Modifikovani nukleozidi, nukleotidi, i nukleinske kiseline, i njihove upotrebe
|
CA2850792A1
(en)
|
2011-10-05 |
2013-04-11 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing aldehyde dehydrogenase
|
AU2012328570B2
(en)
|
2011-10-27 |
2017-08-31 |
Massachusetts Institute Of Technology |
Amino acid derivatives functionalized on the n-terminus capable of forming drug encapsulating microspheres and uses thereof
|
WO2013090186A1
(en)
|
2011-12-14 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleic acids, and acute care uses thereof
|
EP2791364A4
(en)
|
2011-12-14 |
2015-11-11 |
Moderna Therapeutics Inc |
METHODS OF RESPONSE TO A BIOLOGICAL THREAT
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
CA2859691A1
(en)
|
2011-12-21 |
2013-06-27 |
Moderna Therapeutics, Inc. |
Methods of increasing the viability or longevity of an organ or organ explant
|
US20140371302A1
(en)
|
2011-12-29 |
2014-12-18 |
Modema Therapeutics, Inc. |
Modified mrnas encoding cell-penetrating polypeptides
|
EP4372081A2
(en)
|
2011-12-30 |
2024-05-22 |
Cellscript, Llc |
Making and using in vitro-synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
HUE041494T2
(hu)
|
2012-02-24 |
2019-05-28 |
Arbutus Biopharma Corp |
Trialkil-kationos lipidek és alkalmazási módszereik
|
US9877919B2
(en)
|
2012-03-29 |
2018-01-30 |
Translate Bio, Inc. |
Lipid-derived neutral nanoparticles
|
BR112014024131A2
(pt)
|
2012-03-29 |
2017-07-25 |
Shire Human Genetic Therapies |
lipídios catiônicos ionizáveis
|
JP2015518705A
(ja)
|
2012-04-02 |
2015-07-06 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
ヒト疾患に関連する生物製剤およびタンパク質の産生のための修飾ポリヌクレオチド
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US20140275229A1
(en)
|
2012-04-02 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Modified polynucleotides encoding udp glucuronosyltransferase 1 family, polypeptide a1
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US20150050354A1
(en)
|
2012-04-02 |
2015-02-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the treatment of otic diseases and conditions
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
EA201492055A1
(ru)
|
2012-06-08 |
2015-11-30 |
Шир Хьюман Дженетик Терапис, Инк. |
ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
|
EP3536787A1
(en)
|
2012-06-08 |
2019-09-11 |
Translate Bio, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
BR112014029807A2
(pt)
|
2012-06-08 |
2017-06-27 |
Ethris Gmbh |
administração pulmonar de rna mensageiro
|
CA2884870C
(en)
|
2012-08-13 |
2022-03-29 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
EP4074834A1
(en)
|
2012-11-26 |
2022-10-19 |
ModernaTX, Inc. |
Terminally modified rna
|
EP2929035A1
(en)
|
2012-12-07 |
2015-10-14 |
Shire Human Genetic Therapies, Inc. |
Lipidic nanoparticles for mrna delivering
|
US20150315541A1
(en)
|
2012-12-13 |
2015-11-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for altering cell phenotype
|
EP2931319B1
(en)
|
2012-12-13 |
2019-08-21 |
ModernaTX, Inc. |
Modified nucleic acid molecules and uses thereof
|
JP2016504050A
(ja)
|
2013-01-17 |
2016-02-12 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
細胞表現型の改変のためのシグナルセンサーポリヌクレオチド
|
WO2014158795A1
(en)
|
2013-03-12 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Diagnosis and treatment of fibrosis
|
EP2968391A1
(en)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
EP3431592A1
(en)
|
2013-03-14 |
2019-01-23 |
Translate Bio, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
HUE055044T2
(hu)
|
2013-03-14 |
2021-10-28 |
Translate Bio Inc |
MRNS-kódolt ellenanyagok bejuttatására szolgáló eljárások és készítmények
|
EP2970955B1
(en)
|
2013-03-14 |
2018-11-14 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
ES2680595T3
(es)
|
2013-03-14 |
2018-09-10 |
Translate Bio, Inc. |
Evaluación cuantitativa para eficacia de ARN mensajero para tapar
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
ES2647832T3
(es)
|
2013-03-14 |
2017-12-26 |
Translate Bio, Inc. |
Ácidos ribonucleicos con nucleótidos modificados con 4-tio y procedimientos relacionados
|
EA037922B1
(ru)
|
2013-03-14 |
2021-06-07 |
Шир Хьюман Дженетик Терапис, Инк. |
мРНК CFTR И КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ МУКОВИСЦИДОЗА У МЛЕКОПИТАЮЩЕГО
|
CN105209633A
(zh)
|
2013-03-14 |
2015-12-30 |
夏尔人类遗传性治疗公司 |
信使rna加帽效率的定量评估
|
US20160032273A1
(en)
|
2013-03-15 |
2016-02-04 |
Moderna Therapeutics, Inc. |
Characterization of mrna molecules
|
WO2014144711A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Analysis of mrna heterogeneity and stability
|
WO2014152027A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Manufacturing methods for production of rna transcripts
|
ES2795249T3
(es)
|
2013-03-15 |
2020-11-23 |
Translate Bio Inc |
Mejora sinérgica de la administración de ácidos nucleicos a través de formulaciones mezcladas
|
US11377470B2
(en)
|
2013-03-15 |
2022-07-05 |
Modernatx, Inc. |
Ribonucleic acid purification
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
EP2971165A4
(en)
|
2013-03-15 |
2016-11-23 |
Moderna Therapeutics Inc |
DISSOLUTION OF DNA FRAGMENTS IN MRNA MANUFACTURING METHODS
|
WO2014144767A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
US9895443B2
(en)
|
2013-06-26 |
2018-02-20 |
Massachusetts Institute Of Technology |
Multi-tailed lipids and uses thereof
|
EP3971287A1
(en)
|
2013-07-11 |
2022-03-23 |
ModernaTX, Inc. |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
JP6620093B2
(ja)
|
2013-07-23 |
2019-12-11 |
アービュートゥス バイオファーマ コーポレイションArbutus Biopharma Corporation |
メッセンジャーrnaを送達するための組成物及び方法
|
AU2014315287A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
WO2015051173A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc |
Polynucleotide molecules and uses thereof
|
US10385088B2
(en)
|
2013-10-02 |
2019-08-20 |
Modernatx, Inc. |
Polynucleotide molecules and uses thereof
|
WO2015058069A1
(en)
|
2013-10-18 |
2015-04-23 |
Moderna Therapeutics, Inc. |
Compositions and methods for tolerizing cellular systems
|
EP4036241A1
(en)
|
2013-10-22 |
2022-08-03 |
Translate Bio, Inc. |
Cns delivery of mrna and uses thereof
|
CA2928186A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for phenylketonuria
|
ES2954366T3
(es)
|
2013-10-22 |
2023-11-21 |
Translate Bio Inc |
Terapia de ácido ribonucleico mensajero para la deficiencia de argininosuccinato sintetasa
|
WO2015085318A2
(en)
|
2013-12-06 |
2015-06-11 |
Moderna Therapeutics, Inc. |
Targeted adaptive vaccines
|
EP3053585A1
(en)
|
2013-12-13 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
US10059655B2
(en)
|
2013-12-19 |
2018-08-28 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
KR102399799B1
(ko)
|
2013-12-30 |
2022-05-18 |
큐어백 아게 |
인공 핵산 분자
|
US20170002060A1
(en)
|
2014-01-08 |
2017-01-05 |
Moderna Therapeutics, Inc. |
Polynucleotides for the in vivo production of antibodies
|
CA2935878C
(en)
|
2014-03-12 |
2023-05-02 |
Curevac Ag |
Combination of vaccination and ox40 agonists
|
PT3134131T
(pt)
|
2014-04-23 |
2022-03-24 |
Modernatx Inc |
Vacinas de ácidos nucleicos
|
JP6557722B2
(ja)
|
2014-05-30 |
2019-08-07 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
核酸の送達のための生分解性脂質
|
CA2953341C
(en)
|
2014-06-25 |
2023-01-24 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
CN114146063A
(zh)
|
2014-07-02 |
2022-03-08 |
川斯勒佰尔公司 |
信使rna的包封
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
US10415037B2
(en)
|
2014-10-02 |
2019-09-17 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis B virus gene expression
|
WO2016071857A1
(en)
|
2014-11-07 |
2016-05-12 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus expression
|
WO2016077125A1
(en)
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
EP3218508A4
(en)
|
2014-11-10 |
2018-04-18 |
Modernatx, Inc. |
Multiparametric nucleic acid optimization
|
EP3247363A4
(en)
|
2015-01-21 |
2018-10-03 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
WO2016118725A1
(en)
|
2015-01-23 |
2016-07-28 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
WO2016154127A2
(en)
|
2015-03-20 |
2016-09-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for treating hypertriglyceridemia
|
WO2016164762A1
(en)
|
2015-04-08 |
2016-10-13 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor egf-a and intracellular domain mutants and methods of using the same
|
WO2016183366A2
(en)
|
2015-05-12 |
2016-11-17 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing expression of hepatitis d virus rna
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
WO2016197133A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics, Inc. |
Delivering crispr therapeutics with lipid nanoparticles
|
EP3307305A4
(en)
|
2015-06-10 |
2019-05-22 |
Modernatx, Inc. |
TARGETED ADAPTIVE VACCINES
|
PL3310764T3
(pl)
|
2015-06-19 |
2023-11-06 |
Massachusetts Institute Of Technology |
Podstawione alkenylem 2,5-piperazynodiony i ich zastosowanie w kompozycjach do dostarczania środka do osobnika lub komórki
|
WO2017004143A1
(en)
|
2015-06-29 |
2017-01-05 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
US20180208932A1
(en)
|
2015-07-29 |
2018-07-26 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis b virus gene expression
|
WO2017049286A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a morpholino linker
|
PL3350333T3
(pl)
|
2015-09-17 |
2022-03-07 |
Modernatx, Inc. |
Polinukleotydy zawierające region stabilizujący ogon
|
SI3350157T1
(sl)
|
2015-09-17 |
2022-04-29 |
Modernatx, Inc. |
Sestave za doziranje terapevtskih sredstev v celice
|
US20190054112A1
(en)
|
2015-09-18 |
2019-02-21 |
Moderna Therapeutics, Inc. |
Polynucleotide formulations for use in the treatment of renal diseases
|
AU2016343803B2
(en)
|
2015-10-28 |
2021-04-29 |
Acuitas Therapeutics, Inc. |
Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
WO2017117528A1
(en)
|
2015-12-30 |
2017-07-06 |
Acuitas Therapeutics, Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
TWI773666B
(zh)
|
2016-03-30 |
2022-08-11 |
美商英特利亞醫療公司 |
Crispr/cas 組分之脂質奈米粒子調配物
|
CN110114058B
(zh)
*
|
2016-11-10 |
2023-05-26 |
川斯勒佰尔公司 |
用于递送mrna的改进的基于ice的脂质纳米颗粒制剂
|